Primary small-bowel non-Hodgkin's lymphoma: A study of clinical features, pathology, management and prognosis

Journal of International Medical Research

Volumn 35, Issue 3, 2007, Pages 406-415

  Yin, L ^a   Chen, C Q ^a   Peng, C H ^a   Chen, G M ^a   Zhou, H J ^a   Han, B S ^a   Li, H W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Clinicophatological features; Diagnosis; Non Hodgkin's lymphoma; Small bowel neoplasm; Survival

Indexed keywords

ALBUMIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DUODENUM; FEMALE; FOLLOW UP; HEMICOLECTOMY; HUMAN; ILEUM; INTESTINE LYMPHOMA; INTESTINE OBSTRUCTION; INTESTINE RESECTION; JEJUNUM; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; LYMPHADENECTOMY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PANCREATICODUODENECTOMY; PROGNOSIS; RETROSPECTIVE STUDY; T CELL LYMPHOMA; TREATMENT RESPONSE;

EID: 34250883864     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500316     Document Type: Article

References (49)

1. Dincol D, Icli F, Erekul S, et al: Primary gastrointestinal lymphomas in Turkey: a retrospective analysis of clinical features and results of treatment. J Surg Oncol 1992; 51: 270-273.
2. Otter R, Bieger R, Kluin PM, et al: Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 1989; 60: 745-750.
3. Salem P, Anaissie E, Allure C, et al: Non-Hodgkin's lymphomas in the Middle East. A study of 417 patients with emphasis on special features. Cancer 1986; 58: 1162-1166.
4. Koch P, del Valle F, Berdel WE, et al: Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicentric Study GIT NHL 01/92. J Clin Oncol 2001; 19: 3861-3873.
5. Amer MH, El-Akkad S: Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology 1994; 106: 846-858.
6. Radaszkiewicz T, Dragosics B, Bauer P: Gastro-intestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992; 102: 1628-1638.
7. Domizio P, Owen R, Shepherd N, et al: Primary lymphoma of the small intestine: a clinicopathological study of 119 cases. Am J Surg Pathol 1993; 17: 429-442.
8. Rohatiner A, d'Amore F, Coiffier B, et al: Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
9. DeMario M, Liebowitz D: Lymphomas in the immunocompromised patient. Serain Oncol 1998; 25: 492-502.
10. Loftus E, Tremaine W, Habermann T, et al: Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 2000; 95: 2308-2312.
11. Zinzani P, Magagnoli M, Pagliani G, et al: Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica 1997; 82: 305-308.
12. Smedby KE, Akerman M, Hildebrand H, et al: Malignant lymphomas in celiac disease: evidence of increased risk for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54: 54-59.
13. Varghese C, Jose C, Subhashini J, et al: Primary small intestinal lymphoma. Oncology 1992; 49: 340-342.
14. Nakamura S, Matsumoto T, Takeshita M, et. al: A clinicopathologic study of primary small intestine lymphoma. Cancer 2000; 888: 286-294.
15. Morton JE, Leyland MJ, Vaughan Hudson G, et al: Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer 1993; 67: 776-782.
16. Rohatiner A, d'Amore F, Coiffier B, et al: Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
17. Dawson IMP, Comes JS, Morrison BC: Primary malignant lymphoid tumors of the intestinal tract. Br J Surg 1961; 49: 80-89.
18. Baildam AD, Williams GT, Schofield PF: Abdominal lymphoma - the place for surgery. J R Soc Med 1986; 82: 657-660.
19. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic disease of the hematopoietic and lymphoid tissues: report of the clinical advisory meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
20. Musshoff K: Clinical staging classification of non-Hodgkin's lymphomas. Strahlentherapie 1977; 153: 218-221.
21. Ibrahim EM, Ezzat AA, Ei-Weshi AN, et al: Primary intestinal diffuse large B-cell non-Hodgkin's lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol 2001; 12: 53-58.
22. Howdle PD, Jalal PK, Holmes GKT, et al: Primary small-bowel malignancy in the UK and its association with coeliac disease. Q J Med 2003; 96: 345-353
23. Lee J, Kim WS, Kim K, et al: Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma 2004; 45: 339-344.
24. Ahmed S, Singh A, Krauss J, et al: Successful treat ment of refractory tow grade duodenal lymphoma with rituximab, an anti-CD20 monoclonal antibody. Am J Clin Oncol 2003; 26: 408-410.
25. Nalesnik MA, Jaffe R, Starzl TE: The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 1988; 133: 173-192.
26. Levine AM: Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 8-20.
27. Bende RJ, Smit LA, Bossenbroek JG, et al: Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 2003; 162: 105-113.
28. Swinson CM, Slavin G, Coles EC, et al: Coeliac disease and malignancy. Lancet 1983; i: 111-115.
29. Catassi C, Fabiani E, Corrao G, et al: Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-1419.
30. Smedby KE, Akerman M, Hildebrand H, et al: Malignant lymphomas in celiac disease: evidence of increased risks for lymphoma types other than enteropathy T cell lymphoma. Gut 2005; 54: 54-59.
31. Foss HD, Stein H: Pathology of intestinal lymphomas. Recent results. Cancer Res 2000; 156: 33-41.
32. Berney T, Delis S, Kato T, et al: Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation 2002; 74: 1000-1006.
33. Hall CH Jr, Shamma M: Primary intestinal lymphoma complicating Crohn's disease. J Clin Gastroenterol 2003; 36: 332-336.
34. Huang Q, Chang KL, Gaal K, et al: Primary effusion lymphoma with subsequent development of a small bowel mass in an HIV-seropositive patient: a case report and literature review. Am J Surg Pathol 2002; 26: 1363-1367.
35. Chim CS, Loong F, Leung AY, et al: Primary follicular lymphoma of the small intestine. Leuk Lymphoma 2004; 45: 1463-1466.
36. d'Amore F, Christensen BE, Brincker H, et al: Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer 1991; 27: 1201-1208.
37. Fischbach W, Dragosics B, Kolve-Goebeler M-E, et al: Primary gastric B-cell lymphoma: results of a prospective multicenter study. Gastroenterology 2000; 119: 1191-1202.
38. Eser B, Kaplan B, Unal A, et al: Clinicopathologic characteristics and therapeutic outcomes of primary gastrointestinal non-Hodgkin's lymphomas in central Anatolia, in Turkey. Yonsei Med J 2006; 47: 22-33.
39. Rackner VL, Thirlby RC, Ryan JA Jr: Role of surgery in multimodality therapy for gastrointestinal lymphoma. Am J Surg 1991; 161: 570-575.
40. Radman I, Kovacevic-Metelko J, Aurer I, et al: Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study. Croat Med J 2002; 43: 555-560.
41. Bobbi PG, Ghirardelli ML, Cavalli C, et al: The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica 2000; 85: 372-380.
42. Samel S, Wagner J, Hofheinz R, et al: Malignant intestinal non-Hodgkin's lymphoma from the surgical point of view. Onkologie 2002; 25: 268-271.
43. Gopal A, Press O: Clinical applications of anti-CD20 antibodies. J Lab Clin Med 1999; 134: 445-450.
44. Hainsworth JD, Burris III HA, Morrissey LH, et al: Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood 2000; 95: 3052-3056.
45. Pfreundschuh M, Trumper L, Osterborg A, et al: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MINT) Group. Lancet Oncol 2006; 7: 379-391.
46. Daum S, Ullrich R, Heise W, et al: Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol 2003; 21: 2740-2746.
47. Nomura K, Tomikashi K, Matsumoto Y, et al: Small bowel non-Hodgkin's lymphoma remaining in complete remission by surgical resection and adjuvant rituximab therapy. World J Gastroenterol 2005; 11: 4443-4444.
48. Ha C, Cho M-J, Allen P, et al: Primary non-Hodgkin's lymphoma of the small bowel. Radiology 1999; 211: 183-187.
49. Miller TP, Dahlberg S, Cassady JR: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998; 339: 21-26.